These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23369565)

  • 1. Radioembolization of renal cell carcinoma using yttrium-90 microspheres.
    Hamoui N; Gates VL; Gonzalez J; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2013 Feb; 24(2):298-300. PubMed ID: 23369565
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal cell carcinoma detection and systemic therapy with tumour-affine gallium-67 and with yttrium-90 citrate solutions.
    Shukla SK; Limouris GS; Cusumano R; Acconcia A; Cipriani C; Argiro G; Atzei G; Boemi S
    Anticancer Res; 1997; 17(3B):1713-8. PubMed ID: 9179224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
    Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A planning study investigating dual-gated volumetric arc stereotactic treatment of primary renal cell carcinoma.
    Devereux T; Pham D; Kron T; Foroudi F; Supple J; Siva S
    Med Dosim; 2015; 40(1):82-8. PubMed ID: 25498837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres.
    Van den Eynde M; Flamen P; El Nakadi I; Liberale G; Delatte P; Larsimont D; Hendlisz A
    Clin Nucl Med; 2008 Oct; 33(10):697-9. PubMed ID: 18806572
    [No Abstract]   [Full Text] [Related]  

  • 6. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.
    Tong AK; Kao YH; Too CW; Chin KF; Ng DC; Chow PK
    Br J Radiol; 2016 Jun; 89(1062):20150943. PubMed ID: 26943239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.
    Evans KA; Richardson MG; Pavlakis N; Morris DL; Liauw W; Bester L
    J Vasc Interv Radiol; 2010 Oct; 21(10):1521-6. PubMed ID: 20813542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
    Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
    J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
    Dawson LA
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver abscess following radioembolization with yttrium-90 microspheres.
    Korkmaz M; Bozkaya H; Çınar C; Şanal B; Güneyli S; Parıldar M; Oran İ
    Wien Klin Wochenschr; 2014 Dec; 126(23-24):785-8. PubMed ID: 25234938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of radioembolization in identifying patients with favorable tumor biology before living donor liver transplantation.
    Yu YD; Kim DS; Jung SW; Kim Y; Suh SO
    Transplantation; 2014 Sep; 98(5):e47-50. PubMed ID: 25171535
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice.
    Vessella RL; Lange PH; Palme DF; Chiou RK; Elson MK; Wessels BW
    Targeted Diagn Ther; 1988; 1():245-82. PubMed ID: 2979058
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioembolization with 90Y microspheres: technical considerations.
    Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1460-1. PubMed ID: 18004003
    [No Abstract]   [Full Text] [Related]  

  • 14. Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
    Lawrentschuk N; Davis ID; Bolton DM; Scott AM
    BJU Int; 2006 May; 97(5):916-22. PubMed ID: 16643471
    [No Abstract]   [Full Text] [Related]  

  • 15. Invited Commentary: (90)Y Radioembolization.
    Kalva SP; Sutphin PD
    Radiographics; 2015; 35(5):1618-20. PubMed ID: 26230756
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
    Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
    J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma.
    Stillebroer AB; Boerman OC; Desar IM; Boers-Sonderen MJ; van Herpen CM; Langenhuijsen JF; Smith-Jones PM; Oosterwijk E; Oyen WJ; Mulders PF
    Eur Urol; 2013 Sep; 64(3):478-85. PubMed ID: 22980441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival.
    Biederman DM; Titano JJ; Lee KM; Pierobon ES; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Tabori NE; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2015 Nov; 26(11):1630-8. PubMed ID: 26321014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
    J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.